Optiray 320 (Ioversol Injection 68%) - 100 mL Syringe, Ultraject

Optiray™ 320 (ioversol injection)–– part of today’s only fully integrated contrast media delivery system that helps improve efficiency for CT imaging.

Optiray™ 320 contrast agent is lower osmolar, lower viscosity and nonionic. Since 1989, over 140 million doses of Optiray™ contrast agent (all concentrations combined) have been sold. It has a good safety profile, and a broad range of indications. Optiray™ 320 contrast agent is now available in radio frequency identification (RFID) enabled Ultraject™ prefilled syringes. When combined with the RFID enabled Optivantage™ dual-head CT contrast delivery system, Optiray™ contrast media in prefilled syringes are a key component in helping safeguard patients in your care. A large number of packaging configurations in syringes, vials and bottles provides a number of choices to meet your individual patient needs.

Optiray™ 320 contrast agent is injectable and intended for intravascular administration. It is a prescription drug that is intended to be therapeutically and biologically inert when injected into the body for use in organ or tissue enhancement in computed tomography, X-ray and fluoroscopy imaging procedures for which it is approved. Each milliliter of Optiray™ 320 contrast agent contains 678 mg of ioversol, 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer.

MFR: 132390 is a 100mL Syringe, Ultraject prefilled power injector, Case of 20, NDC 000191-323-90